Rapport Therapeutics Inc (RAPP)

07:26 AM

Rapport Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

07:26 AM

12:12 PM

When the Price of (RAPP) Talks, People Listen - news.stocktradersdaily.com

12:12 PM

Apr 17, 2025

Rapport therapeutics chief scientific officer sells $81,310 of stock - Investing.com Australia

Apr 17, 2025

Apr 16, 2025

Rapport therapeutics chief scientific officer sells $81,310 of stock By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 13, 2025

KLP Kapitalforvaltning AS Purchases Shares of 1,900 Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Apr 13, 2025

Apr 13, 2025

48,452 Shares in Rapport Therapeutics (NASDAQ:RAPP) Acquired by Norges Bank - Defense World

Apr 13, 2025

Apr 12, 2025

Comparing Rapport Therapeutics (RAPP) & The Competition - Defense World

Apr 12, 2025

Apr 10, 2025

Rapport Therapeutics (NASDAQ:RAPP) Coverage Initiated at JMP Securities - Defense World

Apr 10, 2025

Apr 08, 2025

JMP Securities Initiates Coverage of Rapport Therapeutics (RAPP) with Market Outperform Recommendation - Nasdaq

Apr 08, 2025

Apr 08, 2025

Citizens JMP sets $28 target for Rapport Therapeutics stock By Investing.com - Investing.com Canada

Apr 08, 2025

Apr 05, 2025

(RAPP) Investment Analysis - news.stocktradersdaily.com

Apr 05, 2025

Apr 02, 2025

nCino Posts Weak Earnings, Joins Tesla And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Apr 02, 2025

Mar 31, 2025

Rapport Therapeutics: Too Early To Be Interesting (NASDAQ:RAPP) - Seeking Alpha

Mar 31, 2025

Mar 31, 2025

Swiss National Bank Purchases New Stake in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 31, 2025

Mar 27, 2025

Analyzing Neurogene (NASDAQ:NGNE) & Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 27, 2025

Mar 26, 2025

Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga

Mar 26, 2025

Mar 26, 2025

(RAPP) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 26, 2025

Mar 26, 2025

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 26, 2025

Mar 23, 2025

Vanda Pharmaceuticals (NASDAQ:VNDA) and Rapport Therapeutics (NASDAQ:RAPP) Financial Contrast - Defense World

Mar 23, 2025

Mar 21, 2025

Rapport Therapeutics to present data at 2025 AAN meeting - TipRanks

Mar 21, 2025

Mar 21, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - GlobeNewswire

Mar 21, 2025

Mar 21, 2025

Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual Meeting - GlobeNewswire Inc.

Mar 21, 2025

Mar 15, 2025

Several Insiders Invested In Rapport Therapeutics Flagging Positive News - simplywall.st

Mar 15, 2025

Mar 15, 2025

Positive Signs As Multiple Insiders Buy Rapport Therapeutics Stock - Yahoo

Mar 15, 2025

Mar 15, 2025

Insider Buying: Rapport Therapeutics Chief Financial Officer Bought US$101k Of Shares - Yahoo Finance

Mar 15, 2025

Mar 14, 2025

Rapport Therapeutics director Wendy Young acquires $61,249 in stock By Investing.com - Investing.com India

Mar 14, 2025

Mar 13, 2025

Rapport Therapeutics CFO Troy Ignelzi buys $100,988 in stock - Investing.com

Mar 13, 2025

Mar 13, 2025

Rapport Therapeutics CFO Troy Ignelzi buys $100,988 in stock By Investing.com - Investing.com India

Mar 13, 2025

Mar 13, 2025

Rapport Therapeutics Executives Acquire Shares - TradingView

Mar 13, 2025

Mar 13, 2025

Rapport Therapeutics director Wendy Young acquires $61,249 in stock - Investing.com

Mar 13, 2025

Mar 11, 2025

Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 11, 2025

Mar 11, 2025

Rapport Therapeutics Reports Q4 Net Loss Of $19.98 Mln - Nasdaq

Mar 11, 2025

Mar 11, 2025

Rapport Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 11, 2025

Mar 11, 2025

Rapport Therapeutics reports Q4 EPS (57c) vs. ($8.01) last year - TipRanks

Mar 11, 2025

Mar 11, 2025

Rapport Therapeutics Inc Q4 Net Loss $20.0 Million -March 11, 2025 at 07:20 am EDT - Marketscreener.com

Mar 11, 2025

Mar 11, 2025

Rhumbline Advisers Has $182,000 Stock Position in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 11, 2025

Mar 07, 2025

New York State Common Retirement Fund Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Mar 07, 2025

Mar 05, 2025

(RAPP) On The My Stocks Page - Stock Traders Daily

Mar 05, 2025

Mar 04, 2025

Head of R&D Robert Lenz to leave Neumora - BioCentury

Mar 04, 2025

Mar 03, 2025

Rapport Therapeutics appoints new chief medical officer By Investing.com - Investing.com Canada

Mar 03, 2025

Mar 03, 2025

Rapport Therapeutics, Inc. Announces Appointment of Jeffrey Sevigny as Chief Medical Officer - Marketscreener.com

Mar 03, 2025

Mar 03, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine Development - The Manila Times

Mar 03, 2025

Mar 03, 2025

Rapport Therapeutics appoints new chief medical officer - Investing.com

Mar 03, 2025

Mar 03, 2025

Rapport Therapeutics Announces Appointment of Dr. Jeffrey - GlobeNewswire

Mar 03, 2025

Feb 22, 2025

Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - Defense World

Feb 22, 2025

Feb 20, 2025

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 8.5%Here's What Happened - MarketBeat

Feb 20, 2025

Feb 13, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat

Feb 13, 2025

Feb 12, 2025

How To Trade (RAPP) - Stock Traders Daily

Feb 12, 2025

Feb 11, 2025

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 5.6%What's Next? - MarketBeat

Feb 11, 2025

Feb 10, 2025

Jennison Associates LLC Acquires Shares of 62,287 Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Feb 10, 2025